NSE: EXPLEOSOL | BSE: 533121

Value Stock, Under Radar

Download real time

707.40 60.50 (9.35%)

New 52W Low in past week

15,932 NSE+BSE Volume

NSE 01 Apr, 2026 10:33 AM (IST)

1,097.9

Market Cap

Below industry Median

Beta 1Year

Average volatility

Expleo Solutions Ltd. share price target and research reports

Name: Latest research reports of Expleo Solutions Ltd. authored by Monarch Networth Capital Limited and published by - Trendlyne research reports.
Item: Expleo Solutions Ltd.
Rating: 3
Author: Monarch Networth Capital Limited

Latest analyst research reports with target prices and PDF download for EXPLEOSOL, BSE:533121 Expleo Solutions Ltd.

Search Inside the pdf :

Expleo Solutions Ltd.

16 Feb 2023

707.40

9.35%

Expleo Solutions - Strong recovery on all fronts

Neutral: Expleo Solutions Ltd.

Recommendation Target

Monarch Networth Capital Limited

Expleo Solutions has lost -26.97% in the last 3 Months

Expleo Solutions Ltd.

13 Aug 2022

707.40

9.35%

Expleo Solutions - Acquisition drives exceptional performance

Buy: Expleo Solutions Ltd.

Monarch Networth Capital Limited

Expleo Solutions Ltd. is trading below all available SMAs

Expleo Solutions Ltd.

20 May 2022

707.40

9.35%

Expleo Solutions Stability in Volatility

Not Rated: Expleo Solutions Ltd.

Monarch Networth Capital Limited

Expleo Solutions has lost -26.97% in the last 3 Months

Expleo Solutions Ltd.

03 Jan 2022

707.40

9.35%

Expleo Solutions - Quality' assurance player ready to cash in

Buy: Expleo Solutions Ltd.

Target

Monarch Networth Capital Limited

INDIA l Institutional Research l IT l 3rd January 2022 Expleo Solutions l Fair Value: 1,900 Quality' assurance player ready to cash in We reiterate our positive stance on the stock and revise our Fair Value to Rs1,900 (earlier Rs1,480) with upward revisions in our FY22/FY23/FY24 estimates driven by robust outlook from the management, synergies from the merger that enhances growth visibility, and focused approach on the Indian entities by the MNC parent. Demand resilience and investments in next-generation technologies (highlighted in our recent...

Expleo Solutions has lost -26.97% in the last 3 Months

Expleo Solutions Ltd.

15 Nov 2021

707.40

9.35%

Expleo Solutions - Exploring uncharted territory

Buy: Expleo Solutions Ltd.

Target

Monarch Networth Capital Limited

We revise our Fair Value to Rs1,480 (earlier Rs1,420) with revisions in our FY22/FY23 estimates driven by strong growth visibility and high demand witnessed across segments. The company posted impressive revenue growth of 10% QoQ (+32% YoY) driven by increasing share of digital services coupled with buoyancy in specialised testing services (led by early investments in next-gen services as highlighted in our recent note) and we believe that this strong revenue growth should sustain going forward. The company's margin profile witnessed expansion sequentially despite persisting supply issues and we believe margins are likely to further expand from current levels. Given the company's focus on digital...

Expleo Solutions Ltd. is trading below all available SMAs

Expleo Solutions Ltd.

26 Oct 2021

707.40

9.35%

Expleo Solutions - TESTing new waters

Buy: Expleo Solutions Ltd.

Monarch Networth Capital Limited

We present a high-conviction investment idea on Expleo Solutions, an under-researched premier quality assurance company, with a fair value of Rs1,420. The company is likely to be a One Stop Solution' provider with the merger of engineering, design and testing capabilities. Its investment in the high-growth next-gen testing segment, where it has a leadership position, has started to reap benefits. We believe, a niche company like Expleo Solutions is attractively placed considering its specialized offerings, growth visibility, MNC parentage, superior financials, increased outsourcing trend, traction in smaller deals...

Expleo Solutions Ltd. is trading below all available SMAs

Expleo Solutions Ltd.

07 Aug 2017

707.40

9.35%

SQS India BFSI Ltd: Impact of Macro Headwinds Still Hurting;... (Aug 07, 2017)

Hold: Expleo Solutions Ltd.

Recommendation Target

Karvy

EBITDA Margins recovered by 618 bps QoQ: The company has witnessedmany challenges over the year FY17 starting with Brexit which has an impact on depreciation of British Pound which took significant hit to ~ 25% of business from UK during the year.

Expleo Solutions Ltd. is trading below all available SMAs

Expleo Solutions Ltd.

01 Aug 2017, 12:00AM

707.40

9.35%

Result Update - SQS India BFSI Ltd

Hold: Expleo Solutions Ltd.

Axis Direct

SQS India BFSI Ltd delivered a modest performance in Q1FY18, with earnings (PAT) coming in at Rs 8.7 Cr, down 3.3% Y-o-Y on account of decline in sales and higher employee expenses (% of sales). In Q1FY18, employee expenses as a percentage of sales were reported at 64.7% as against 59.9% in Q1FY17. ..

Expleo Solutions has lost -27.92% in the last 6 Months

Expleo Solutions Ltd.

08 May 2017

707.40

9.35%

SQS India BFSI Ltd: Weak Q4FY17 Due to Macro Environment Hea... (May 08, 2017)

Buy: Expleo Solutions Ltd.

Target

Karvy

Drop in revenue; Margins recovered by 414 bps QoQ: SQS recorded revenue of Rs. 575 Mn in Q4FY17 with a drop of 5.6% QoQ. However, EBITDA margins are at 20.3% which is up by by 414 bps QoQ. For the whole year, the company recordedrevenue of Rs. 2600 Mn which is down by 1.6% YoY. The company has witnessed many challenges over the year FY17 starting with Brexit which was unexpected and thus has an impact on depreciation of British Pound which took significant hit to ~ 25% of business from UK during the year.

Expleo Solutions Ltd. is trading below all available SMAs

Expleo Solutions Ltd.

04 May 2017

707.40

9.35%

Result Update:SQS India BFSI

Hold: Expleo Solutions Ltd.

Target

Axis Direct

SQS India BFSI Ltd delivered a modest performance in Q4FY17, with earnings (PAT) coming in at Rs 4.4 Cr, down 58.8% Y-o-Y on account of decline in sales and higher other expenses.

Expleo Solutions has lost -27.92% in the last 6 Months

Is Expleo Solutions Ltd. worth buying?

111 Votes:

Buy 81.08%

Sell 10.81%

Hold 8.11%